Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesOmar Abdel‐Wahab, Ross L. Levine, Cyrus V. Hedvat et al.|Blood|2009Cited by 718
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine modelsPaola Rivera-Muñoz, Sébastien Malinge|Blood Advances|2018Cited by 13